巨细胞动脉炎的颅部受累
本文为综述,讨论巨细胞动脉炎颅部表现的当前认识、临床诊疗路径及未来研究方向,涉及影像学显示病变常超出典型颅动脉而累及主动脉及其近端分支,以及近5年分类标准与管理、影像、达标治疗推荐的发展与更新。
要点
- 影像学显示巨细胞动脉炎常超出典型颅动脉,累及主动脉及其近端分支。
- 对巨细胞动脉炎病理生理的理解促进多种潜在治疗药物出现,旨在减少糖皮质激素需求并预防复发。
- 近5年已制定或更新巨细胞动脉炎分类标准及管理、影像和达标治疗推荐。
核心结论
- 本文旨在讨论巨细胞动脉炎颅部表现的当前认识、临床诊疗方法及研究与患者照护的未来方向。
研究设计与样本
- 本文为综述(Series paper),检索范围原文未报告。
主要发现
- 影像学研究显示巨细胞动脉炎常超出典型颅动脉,也累及主动脉及其近端分支等大血管。
- 对巨细胞动脉炎病理生理理解的进展促成多种潜在治疗药物,旨在减少糖皮质激素治疗需求并预防复发。
- 近5年已制定或更新巨细胞动脉炎分类标准以及管理、影像和达标治疗推荐。
- 当前研究涵盖基础、转化和临床研究的广泛领域。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since its first clinical description in 1890, extensive research has advanced our understanding of giant cell arteritis, leading to improvements in both diagnosis and management for affected patients. Imaging studies have shown that the disease frequently extends beyond the typical cranial arteries, also affecting large vessels such as the aorta and its proximal branches. Meanwhile, advances in comprehending the underlying pathophysiology of giant cell arteritis have given rise to numerous potential therapeutic agents, which aim to minimise the need for glucocorticoid treatment and prevent flares. Classification criteria for giant cell arteritis, as well as recommendations for management, imaging, and treat-to-target have been developed or updated in the last 5 years, and current research encompasses a broad spectrum covering basic, translational, and clinical research. In this Series paper, we aim to discuss the current understanding of giant cell arteritis with cranial manifestations, describe the clinical approach to this condition, and explore future directions in research and patient care.
引用
- Bosch P, Espigol-Frigolé G, Cid MC, et al. Cranial involvement in giant cell arteritis. Lancet Rheumatol. 2024. PMID: 38574747. doi:10.1016/S2665-9913(24)00024-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。